VKORC1 and Novel CYP2C9 Variation Predict Warfarin Response in Alaska Native and American Indian People

Article English OPEN
Lindsay M. Henderson; Renee F. Robinson; Lily Ray; Burhan A. Khan; Tianran Li; Denise A. Dillard; Brian D. Schilling; Mike Mosley; Patricia L. Janssen; Alison E. Fohner; Allan E. Rettie; Kenneth E. Thummel; Timothy A. Thornton; David L. Veenstra;

Alaska Native and American Indian (AN/AI) people have unique pharmacogene variation that may affect warfarin disposition and therapeutic response. We performed targeted genotyping for cytochrome P450 (CYP)2C9, vitamin K epoxide oxidase reductase complex subunit 1 (VKORC... View more
Share - Bookmark